CLINICAL_TRIALS
trial_result
· 2025-07-15
Clinical Trial Update: A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer [Phase 3]
Summary
A Phase 3 trial evaluating abemaciclib in combination with hormone therapy for early breast cancer was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms | Phase 3 | Status: TERMINATED | Results posted: 2025-07-15